Your browser doesn't support javascript.
loading
Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19).
Chen, Chong-Xiang; Hu, Fang; Wei, Jin; Yuan, Le-Tao; Wen, Tian-Meng; Gale, Robert Peter; Liang, Yang.
Afiliação
  • Chen CX; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hu F; State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.
  • Wei J; Department of ICU, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yuan LT; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wen TM; Department of Hematology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Gale RP; School of Public Health, Sun Yat-sen University, Guangzhou, China.
  • Liang Y; School of Public Health, Sun Yat-sen University, Guangzhou, China.
Leukemia ; 35(6): 1661-1670, 2021 06.
Article em En | MEDLINE | ID: mdl-34002026
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article